Document and Entity Information
Document and Entity Information - $ / shares | May 14, 2020 | Mar. 31, 2020 |
Details | ||
Registrant CIK | 0001576873 | |
Fiscal Year End | --09-30 | |
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2020 | |
Document Transition Report | false | |
Entity File Number | 000-55088 | |
Entity Registrant Name | AMERICAN BATTERY METALS CORP | |
Entity Incorporation, State or Country Code | NV | |
Entity Tax Identification Number | 33-1227980 | |
Entity Address, Address Line One | 930 Tahoe Blvd. Suite 802-16 | |
Entity Address, City or Town | Incline Village | |
Entity Address, State or Province | NV | |
Entity Address, Postal Zip Code | 89451 | |
Entity Address, Address Description | Address of principal executive offices | |
City Area Code | 775 | |
Local Phone Number | 473-4744 | |
Phone Fax Number Description | Registrant's telephone number | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Listing, Par Value Per Share | $ 0.001 | |
Entity Common Stock, Shares Outstanding | 346,336,936 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2020 | |
Document Fiscal Period Focus | Q2 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) | Mar. 31, 2020 | Sep. 30, 2019 |
Current assets | ||
Cash | $ 282,374 | $ 7,371 |
Prepaid expenses | 126,053 | 50,073 |
Total current assets | 408,427 | 57,444 |
Investment in joint venture | 35,250 | 35,250 |
Total assets | 443,677 | 92,694 |
Current liabilities | ||
Accounts payable and accrued liabilities | 613,429 | 585,797 |
Due to related parties | 562,449 | 458,269 |
Derivative Liability, Current | 3,776,294 | 3,437,200 |
Convertible Notes payable, net of unamortized discount | 224,239 | 398,348 |
Total current liabilities | 5,176,411 | 4,879,614 |
Convertible note payable, non-current potion, net of unamortized discount of $nil and $149,458, respectively | 0 | 542 |
Total liabilities | 5,176,411 | 4,880,156 |
STOCKHOLDERS' DEFICIT | ||
Preferred Stock, Value, Issued | 300 | 0 |
Common Stock, Value, Issued | 328,418 | 132,678 |
Share subscription received | 1,125,000 | 0 |
Additional paid-in capital | 54,165,137 | 44,970,398 |
Accumulated deficit | (60,351,589) | (49,890,538) |
Total stockholders' deficit | (4,732,734) | (4,787,462) |
Total liabilities and stockholders' deficit | $ 443,677 | $ 92,694 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) - Parenthetical - USD ($) | Mar. 31, 2020 | Sep. 30, 2019 |
Details | ||
Debt Instrument, Unamortized Discount, Current | $ 2,143,261 | $ 3,094,911 |
Debt Instrument, Unamortized Discount, Noncurrent | $ 0 | $ 149,458 |
Preferred Stock, Shares Authorized | 500,000 | 500,000 |
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock, Shares Issued | 300,000 | 0 |
Preferred Stock, Shares Outstanding | 300,000 | 0 |
Common Stock, Shares Authorized | 1,200,000,000 | 1,200,000,000 |
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares, Issued | 328,418,880 | 132,678,133 |
Common Stock, Shares, Outstanding | 328,418,880 | 132,678,133 |
Condensed Consolidated Statemen
Condensed Consolidated Statement of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | Mar. 31, 2020 | Mar. 31, 2019 | |
Details | ||||
Revenues | $ 0 | $ 0 | $ 0 | $ 0 |
Operating expenses | ||||
Exploration costs | 229,335 | 5,460 | 240,646 | 25,080 |
General and administrative | 1,786,600 | 6,450,636 | 2,858,420 | 7,593,232 |
Net loss from operations | (2,015,935) | (6,456,096) | (3,099,066) | (7,618,312) |
Other income (expense) | ||||
Change in fair value of derivative liability | (3,558,652) | (235,853) | (3,623,387) | (944,008) |
Interest expense | (2,503,804) | (439,474) | (4,435,612) | (717,164) |
Gain on settlement of debt | 565,405 | 568,218 | 693,268 | 146,473 |
Other income | 0 | 0 | 3,746 | 0 |
Total other income (expense) | (5,497,051) | (107,109) | (7,361,985) | (1,514,699) |
Net loss | $ (7,512,986) | $ (6,563,205) | $ (10,461,051) | $ (9,133,011) |
Net loss per share, basic and diluted | $ (0.03) | $ (0.06) | $ (0.05) | $ (0.09) |
Weighted average shares outstanding, basic and diluted | 266,995,894 | 114,162,697 | 208,416,834 | 106,790,885 |
Condensed Consolidated Statem_2
Condensed Consolidated Statement of Stockholder's Deficit (Unaudited) - USD ($) | Preferred Stock | Common Stock | Additional Paid-in Capital | Retained Earnings | Total | Share Subscriptions $ |
Equity Balance, Starting at Sep. 30, 2018 | $ 0 | $ 93,331 | $ 34,739,491 | $ (37,265,334) | $ (2,432,512) | |
Shares Outstanding, Starting at Sep. 30, 2018 | 0 | 93,331,449 | ||||
Stock Issued During Period, Value, Issued for Services | $ 0 | $ 3,200 | 485,800 | 0 | 489,000 | |
Stock Issued During Period, Shares, Issued for Services | 0 | 3,200,000 | ||||
Stock Issued During Period, Value, Acquisitions | $ 0 | $ 250 | 35,000 | 0 | 35,250 | |
Stock Issued During Period, Shares, Acquisitions | 0 | 250,000 | ||||
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | $ 0 | $ 5.754 | 867,078 | 0 | 872,832 | |
Stock Issued During Period, Shares, Conversion of Convertible Securities | 0 | 5,753,660 | ||||
Net Income (Loss) | $ 0 | $ 0 | 0 | (2,569,806) | (2,569,806) | |
Shares Outstanding, Ending at Dec. 31, 2018 | 0 | 102,535,109 | ||||
Equity Balance, Ending at Dec. 31, 2018 | $ 0 | $ 102,535 | 36,127,369 | (39,835,140) | (3,605,236) | |
Equity Balance, Starting at Sep. 30, 2018 | $ 0 | $ 93,331 | 34,739,491 | (37,265,334) | (2,432,512) | |
Shares Outstanding, Starting at Sep. 30, 2018 | 0 | 93,331,449 | ||||
Fair value of share purchase warrants | 0 | |||||
Shares Outstanding, Ending at Mar. 31, 2019 | 0 | 114,328,092 | ||||
Equity Balance, Ending at Mar. 31, 2019 | $ 0 | $ 114,328 | 42,496,356 | (46,398,345) | (3,787,661) | |
Equity Balance, Starting at Dec. 31, 2018 | $ 0 | $ 102,535 | 36,127,369 | (39,835,140) | (3,605,236) | |
Shares Outstanding, Starting at Dec. 31, 2018 | 0 | 102,535,109 | ||||
Stock Issued During Period, Value, Issued for Services | $ 0 | $ 19,550 | 5,819,810 | 0 | 5,839,360 | |
Stock Issued During Period, Shares, Issued for Services | 0 | 19,550,000 | ||||
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | $ 0 | $ 2,243 | 539,177 | 0 | 541,420 | |
Stock Issued During Period, Shares, Conversion of Convertible Securities | 0 | 2,242,983 | ||||
Cancellation of shares, Value | $ 0 | $ (10,000) | 10,000 | 0 | 0 | |
Cancellation of shares, Shares | 0 | (10,000,000) | ||||
Net Income (Loss) | $ 0 | $ 0 | 0 | (6,563,205) | (6,563,205) | |
Shares Outstanding, Ending at Mar. 31, 2019 | 0 | 114,328,092 | ||||
Equity Balance, Ending at Mar. 31, 2019 | $ 0 | $ 114,328 | 42,496,356 | (46,398,345) | (3,787,661) | |
Equity Balance, Starting at Sep. 30, 2019 | $ 0 | $ 132,678 | 44,970,398 | (49,890,538) | (4,787,462) | $ 0 |
Shares Outstanding, Starting at Sep. 30, 2019 | 0 | 132,678,133 | ||||
Stock Issued During Period, Value, Issued for Services | $ 0 | $ 5,560 | 227,960 | 0 | 233,520 | 0 |
Stock Issued During Period, Shares, Issued for Services | 0 | 5,560,000 | ||||
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | $ 0 | $ 29,555 | 1,143,889 | 0 | 1,173,444 | 0 |
Stock Issued During Period, Shares, Conversion of Convertible Securities | 0 | 29,554,757 | ||||
Stock Issued During Period, Value, New Issues | $ 300 | $ 0 | (300) | 0 | 0 | 0 |
Stock Issued During Period, Shares, New Issues | 300,000 | 0 | ||||
Stock Issued During Period, Value, Stock Options Exercised | $ 0 | $ 2,997 | (2,997) | 0 | 0 | 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 0 | 2,996,985 | ||||
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | $ 0 | $ 0 | 94,786 | 0 | 94,786 | 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 0 | 0 | ||||
Stock Issued During Period, Value, Other | $ 0 | $ 0 | 0 | 0 | 275,000 | 275,000 |
Stock Issued During Period, Shares, Other | 0 | 0 | ||||
Net Income (Loss) | $ 0 | $ 0 | 0 | (2,948,065) | (2,948,065) | 0 |
Shares Outstanding, Ending at Dec. 31, 2019 | 300,000 | 170,789,875 | ||||
Equity Balance, Ending at Dec. 31, 2019 | $ 300 | $ 170,790 | 46,433,736 | (52,838,603) | (5,958,777) | 275,000 |
Equity Balance, Starting at Sep. 30, 2019 | $ 0 | $ 132,678 | 44,970,398 | (49,890,538) | $ (4,787,462) | 0 |
Shares Outstanding, Starting at Sep. 30, 2019 | 0 | 132,678,133 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 4,310,807 | |||||
Fair value of share purchase warrants | $ 153,314 | |||||
Shares Outstanding, Ending at Mar. 31, 2020 | 300,000 | 328,418,880 | ||||
Equity Balance, Ending at Mar. 31, 2020 | $ 300 | $ 328,418 | 54,165,137 | (60,351,589) | (4,732,734) | 1,125,000 |
Equity Balance, Starting at Dec. 31, 2019 | $ 300 | $ 170,790 | 46,433,736 | (52,838,603) | (5,958,777) | 275,000 |
Shares Outstanding, Starting at Dec. 31, 2019 | 300,000 | 170,789,875 | ||||
Stock Issued During Period, Value, Issued for Services | $ 0 | $ 17,236 | 672,212 | 0 | 689,448 | 0 |
Stock Issued During Period, Shares, Issued for Services | 0 | 17,236,200 | ||||
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | $ 0 | $ 139,078 | 7,001,975 | 0 | 7,141,053 | 0 |
Stock Issued During Period, Shares, Conversion of Convertible Securities | 0 | 139,078,983 | ||||
Stock Issued During Period, Value, Stock Options Exercised | $ 0 | $ 1,314 | (1,314) | 0 | 0 | 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 0 | 1,313,822 | ||||
Stock Issued During Period, Value, Other | $ 0 | $ 0 | 0 | 0 | 850,000 | 850,000 |
Stock Issued During Period, Shares, Other | 0 | 0 | ||||
Fair value of share purchase warrants | $ 0 | $ 0 | 58,528 | 0 | 58,528 | 0 |
Net Income (Loss) | $ 0 | $ 0 | 0 | (7,512,986) | (7,512,986) | 0 |
Shares Outstanding, Ending at Mar. 31, 2020 | 300,000 | 328,418,880 | ||||
Equity Balance, Ending at Mar. 31, 2020 | $ 300 | $ 328,418 | $ 54,165,137 | $ (60,351,589) | $ (4,732,734) | $ 1,125,000 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Operating Activities | ||
Net loss | $ (10,461,051) | $ (9,133,011) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Accretion expense | 3,290,632 | 645,235 |
Change in fair value of derivative liability | 3,623,387 | 944,008 |
Discount on convertible notes payable | 937,287 | 67,754 |
Fair value of share purchase warrants | 153,314 | 0 |
Shares issued for mineral property exploration costs | (693,268) | (146,473) |
Shares issued for services | 922,968 | 6,328,360 |
Changes in operating assets and liabilities: | ||
Prepaid expenses | (75,980) | 115,705 |
Accounts payable and accrued liabilities | 230,043 | 98,844 |
Due to related parties | 104,180 | 113,094 |
Financing Activities | ||
Proceeds from issuance of convertible notes payable | 1,973,750 | 1,944,000 |
Proceeds from private placement subscriptions | 1,125,000 | 0 |
Repayment of convertible notes payable | (855,259) | (752,736) |
Net Cash Provided By Financing Activities | 2,243,491 | 1,191,264 |
Net Cash Used In Operating Activities | (1,968,488) | (966,484) |
Change in Cash | 275,003 | 224,780 |
Cash and Cash Equivalents, at Carrying Value, Beginning Balance | 7,371 | 122,769 |
Cash and Cash Equivalents, at Carrying Value, Ending Balance | 282,374 | 347,549 |
Non-cash investing and financing activities: | ||
Derivative additions associated with convertible notes | 2,029,525 | 1,939,539 |
Original issue discount on convertible debentures | 113,300 | 99,750 |
Common shares issued for conversion of convertible notes payable | 8,314,497 | 1,414,252 |
Common shares issued on the exercise of cashless warrants | 4,311 | 0 |
Preferred shares issued to officers and directors | $ 300 | $ 0 |
1. Organization and Nature of O
1. Organization and Nature of Operations | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
1. Organization and Nature of Operations | 1. Organization and Nature of Operations The accompanying unaudited consolidated financial statements of American Battery Metals Corporation (formerly Oroplata Resources, Inc.) have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive consolidated financial statements and should be read in conjunction with our audited consolidated financial statements for the year ended September 30, 2019, included in our Annual Report on Form 10-K for the year ended September 30, 2019. The Company was incorporated under the laws of the state of Nevada on October 6, 2011 for the purpose of acquiring and developing mineral properties. The Company has a wholly-owned subsidiary called Oroplata Exploraciones E Ingenieria SRL, which was incorporated in the Dominican Republic on January 10, 2012. On July 26, 2016, the Company incorporated Lithortech Resources Inc., a Nevada company, as a wholly-owned subsidiary. The Company currently holds mineral rights in the Western Nevada Basin of Nye County in the state of Nevada. Going Concern The recent outbreak of the novel coronavirus COVID-19, which was declared a pandemic by the World Health Organization on March 11, 2020, has led to adverse impacts on the U.S. and global economies, disruptions of financial markets, and created uncertainty regarding potential impacts to the CompanyÂ’s supply chain and operations. The COVID-19 pandemic has impacted and could further impact the CompanyÂ’s operations and the operations of the CompanyÂ’s suppliers and vendors as a result of quarantines, facility closures, and travel and logistics restrictions. The extent to which the COVID-19 pandemic impacts the CompanyÂ’s business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to the duration, spread, severity, and impact of the COVID-19 pandemic, the effects of the COVID-19 pandemic on the CompanyÂ’s suppliers and vendors and the remedial actions and stimulus measures adopted by local and federal governments, and to what extent normal economic and operating conditions can resume. The management team is closely following the progression of COVID-19 and its potential impact on the Company. Even after the COVID-19 pandemic has subsided, the Company may experience adverse impacts to its business as a result of any economic recession or depression that has occurred or may occur in the future. Therefore, the Company cannot reasonably estimate the impact at this time our business, liquidity, capital resources and financial results. These unaudited consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As at March 31, 2020, the Company has not earned revenue, has a working capital deficit of $4,767,984, and an accumulated deficit of $60,351,589. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to identify future investment opportunities and obtain the necessary debt or equity financing, and generating profitable operations from the CompanyÂ’s future operations. If the Company is able to obtain financing, there is no certainty that terms will be favorable to the Company. These factors raise substantial doubt regarding the CompanyÂ’s ability to continue as a going concern. These unaudited consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. |
2. Summary of Significant Accou
2. Summary of Significant Accounting Policies | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
2. Summary of Significant Accounting Policies | 2. Summary of Significant Accounting Policies (a) The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is September 30. (b) These condensed consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Oroplata Exploraciones E Ingenieria SRL, Lithortech Resources Inc., and ABMC AG, LLC. All inter-company accounts and transactions have been eliminated on consolidation. |
3. Convertible Notes Payable
3. Convertible Notes Payable | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
3. Convertible Notes Payable | 3. Convertible Notes Payable (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m) (n) (o) (p) (q) (r) (s) (t) (u) (v) (w) (x) (y) (z) (aa) (bb) (cc) (dd) (ee) (ff) (gg) (hh) (ii) (jj) (kk) (ll) (mm) (nn) (oo) (pp) (qq) (rr) |
4. Related Party Transactions
4. Related Party Transactions | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
4. Related Party Transactions | 4. Related Party Transactions (a) (b) (c) (d) |
5. Investment in Joint Venture
5. Investment in Joint Venture | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
5. Investment in Joint Venture | 5. Investment in Joint Venture On October 8, 2018, the Company entered into a joint venture agreement with CINC Industries Inc. (“CINC”), a Nevada company, for a period of five years whereby the joint venture will propagate the sale of a new process for extraction of lithium salt from salt brine solutions using CINC’s existing and future processing equipment. As part of the joint venture, each of CINC and the Company holds a 50% interest in the joint venture. CINC is responsible for completing testing on the pilot project, providing training to the Company for use of its processing equipment, manufacturing up to 20 test units, and support and product development, as well as shared costs on other personnel utilized in the joint venture company. The Company is responsible for the initial funding for all equipment and associated expenses, the cost of the lease space, and marketing and sales of the joint venture agreement. The joint venture is committed to acquiring a minimum amount of processing equipment, goods, accessories, and/or materials totalling: (i) $1,000,000 by October 8, 2020; (ii) $3,000,000 by October 8, 2021; (iii) $6,000,000 by October 8, 2022; and (v) $10,000,000 by October 8, 2023. In the event that the joint venture fails to meet the minimum amounts above, the Company will lose the exclusive right to market, promote and sell the processing equipment provided by CINC. As part of the joint venture agreement, the Company issued 250,000 common shares to CINC. Refer to Note 7(b). |
6. Derivative Liabilities
6. Derivative Liabilities | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
6. Derivative Liabilities | 6. Derivative Liabilities The Company records the fair value of the conversion price of the convertible debentures as disclosed in Note 4 in accordance with ASC 815, Derivatives and Hedging. The fair value of the derivatives was calculated using a multi-nominal lattice model. The fair value of the derivative liabilities is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statement of operations. For the six months ended March 31, 2020, the Company recorded a loss on the change in the fair value of derivative liability of $3,623,387 (2019 - $944,008). As at March 31, 2020, the Company recorded a derivative liability of $3,776,294 (September 30, 2019 - $$3,437,200). The following inputs and assumptions were used to value the derivative liabilities outstanding during the periods ended March 31, 2020 and September 30, 2019: March 31, 2020 September 30, 2019 Expected volatility 70-319% 75-151% Risk free rate 1.41% 1.75% Expected life (in years) 0.2-1.0 0.2-1.0 A summary of the activity of the derivative liability is shown below: $ Balance, September 30, 2019 3,437,200 Derivative additions associated with convertible notes 2,029,525 Adjustment for conversion/repayment (5,313,818) Mark to market adjustment at March 31, 2020 3,623,387 Balance, March 31, 2020 3,776,294 |
7. Common Stock
7. Common Stock | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
7. Common Stock | 7. Common Shares The CompanyÂ’s authorized common stock consists of 1,200,000,000 shares of common stock, with par value of $0.001, and authorized Series A preferred stock of 500,000 shares of preferred stock, with par value of $0.001. On October 1, 2019, the Company issued 300,000 Series A preferred stock to officers and directors of the Company for no consideration. The preferred stock has no conversion rights, not entitled to receive dividends, carries voting rights of 1,000 votes per share of preferred stock, and is redeemable at the option of the Company at par value of $0.001 per share. On October 3, 2019, the Company issued 917,777 common shares with a fair value of $49,560 for the conversion of $30,000 of notes payable, $2,225 of accrued interest, and $23,675 of derivative liability resulting in a gain on settlement of debt of $6,340. On October 8, 2019, the Company issued 577,496 common shares with a fair value of $31,185 for the conversion of $15,000 of notes payable, $500 of fees, and $17,800 of derivative liability resulting in a gain on settlement of debt of $2,115. On October 10, 2019, the Company issued 2,036,114 common shares with a fair value of $97,733 for the conversion of $55,000 of notes payable, $4,129 of accrued interest, and $47,710 of derivative liability resulting in a gain on settlement of debt of $9,106. On October 15, 2019, the Company issued 465,723 common shares with a fair value of $29,341 for the conversion of $12,000 of notes payable, $500 of fees, and $18,440 of derivative liability resulting in a gain on settlement of debt of $1,599. On October 17, 2019, the Company issued 502,980 common shares with a fair value of $25,149 for the conversion of $13,000 of notes payable, $500 of fees, and $13,747 of derivative liability resulting in a gain on settlement of debt of $2,098. On October 18, 2019, the Company issued 1,113,981 common shares with a fair value of $54,028 for the conversion of $30,000 of notes payable, $2,350 of accrued interest, and $27,088 of derivative liability resulting in a gain on settlement of debt of $5,410. On October 21, 2019, the Company issued 542,526 common shares with a fair value of $29,242 for the conversion of $12,000 of notes payable, $500 of fees, $2,061 of accrued interest, and $16,874 of derivative liability resulting in a gain on settlement of debt of $2,193. On October 25, 2019, the Company issued 559,768 common shares with a fair value of $27,429 for the conversion of $14,500 of notes payable, $500 of fees, $24 of accrued interest, and $15,781 of derivative liability resulting in a gain on settlement of debt of $3,376. On October 25, 2019, the Company issued 481,557 common shares with a fair value of $23,596 for the conversion of $10,500 of notes payable, $500 of fees, $1,925 of accrued interest and $13,570 of derivative liability resulting in a gain on settlement of debt of $2,899. On October 28, 2019, the Company issued 2,996,985 common shares for the exercise of cashless warrants. On October 30, 2019, the Company issued 744,949 common shares with a fair value of $36,503 for the conversion of $20,000 of notes payable, $1,633 of accrued interest, and $19,841 of derivative liability resulting in a gain on settlement of debt of $4,972. On October 31, 2019, the Company issued 500,000 common shares with a fair value of $24,500 for the conversion of $9,500 of notes payable, $500 of fees, and $16,152 of derivative liability resulting in a gain on settlement of debt of $1,652. On November 4, 2019, the Company issued 820,497 common shares with a fair value of $33,640 for the conversion of $20,000 of notes payable, $1,661 of accrued interest and derivative liability of $17,362 resulting in a gain on settlement of debt of $5,383. On November 8, 2019, the Company issued 815,396 common shares with a fair value of $35.877 for the conversion of $6,234 of notes payable, $1,645 of accrued interest, $13,647 of finance penalties, and $19,231 of derivative liability resulting in a gain on settlement of debt of $4,880. On November 8, 2019, the Company issued 5,560,000 common shares with a fair value of $233,520 for consulting services including 1,000,000 common shares with a fair value of $42,000 to a director of the Company. On November 12, 2019, the Company issued 972,587 common shares with a fair value of $39,876 for the conversion of $25,000 of notes payable, $1,653 of accrued interest, and $20,360 of derivative liability resulting in a gain on settlement of debt of $7,137. On November 20, 2019, the Company issued 994,354 common shares with a fair value of $35,797 for the conversion of $20,000 of notes payable, $1,367 of accrued interest, and $19,506 of derivative liability resulting in a gain on settlement of debt of $5,076. On November 20, 2019, the Company issued 1,986,954 common shares with a fair value of $71,531 for the conversion of $40,000 of notes payable, $2,696 of accrued interest, and $37,954 of derivative liability resulting in a gain on settlement of debt of $9,119. On November 21, 2019, the Company issued 850,000 common shares with a fair value of $34,000 for the conversion of $11,825 of notes payable, $500 of fees, and $23,375 of derivative liability resulting in a gain on settlement of debt of $1,700. On November 29, 2019, the Company issued 996,680 common shares with a fair value of $37,874 for the conversion of $20,000 of notes payable, $1,417 of accrued interest, and $21,476 of derivative liability resulting in a gain on settlement of debt of $5,018. On December 6, 2019, the Company issued 607,477 common shares with a fair value of $20,958 for the conversion of $13,000 of notes payable and $11,339 of derivative liability resulting in a gain on settlement of debt of $3,381. On December 9, 2019, the Company issued 746,269 common shares with a fair value of $25,224 for the conversion of $15,000 of notes payable and $14,028 of derivative liability resulting in a gain on settlement of debt of $3,804. On December 10, 2019, the Company issued 999,524 common shares with a fair value of $32,984 for the conversion of $20,000 of notes payable, $1,478 of accrued interest, and $16,607 of derivative liability resulting in a gain on settlement of debt of $5,101. On December 11, 2019, the Company issued 845,771 common shares with a fair value of $25,458 for the conversion of $17,000 of notes payable and $13,874 of derivative liability resulting in a gain on settlement of debt of $5,416. On December 12, 2019, the Company issued 700,000 common shares with a fair value of $22,820 for the conversion of $9,650 of notes payable, $500 of fees, and $14,396 of derivative liability resulting in a gain on settlement of debt of $1,726. On December 13, 2019, the Company issued 703,704 common shares with a fair value of $22,167 for the conversion of $10,000 of notes payable, $3,300 of accrued interest, and $12,107 of derivative liability resulting in a gain on settlement of debt of $3,240. On December 13, 2019, the Company issued 822,281 common shares with a fair value of $25,902 for the conversion of $15,000 of notes payable, $500 of fees, and $12,103 of derivative liability resulting in a gain on settlement of debt of $1,701. On December 16, 2019, the Company issued 2,079,180 common shares with a fair value of $62,375 for the conversion of $40,000 of notes payable, $2,981 of accrued interest, and $33,668 of derivative liability resulting in a gain on settlement of debt of $14,274. On December 16, 2019, the Company issued 567,874 common shares with a fair value of $17,036 for the conversion of $7,000 of notes payable, $500 of fees, $2,872 of accrued interest, and $7,416 of derivative liability resulting in a gain on settlement of debt of $752. On December 17, 2019, the Company issued 1,047,754 common shares with a fair value of $35,624 for the conversion of $20,000 of notes payable, $1,517 of accrued interest, and $16,552 of derivative liability resulting in a gain on settlement of debt of $2,444. On December 24, 2019, the Company issued 932,920 common shares with a fair value of $38,670 for the conversion of $6,650 of notes payable, $500 of fees, and $29,558 of derivative liability resulting in a loss of settlement of debt of $1,962. On December 24, 2019, the Company issued 1,561,157 common shares with a fair value of $64,710 for the conversion of $25,000 of notes payable, $1,646 of accrued interest, and $43,120 of derivative liability resulting in a gain on settlement of debt of $5,056. On December 27, 2019, the Company issued 896,925 common shares with a fair value of $30,047 for the conversion of $14,000 of notes payable, $500 of fees, $133 of accrued interest, and $16,948 of derivative liability resulting in a gain on settlement of debt of $1,535. On December 30, 2019, the Company issued 1,164,572 common shares with a fair value of $32,608 for the conversion of $18,500 of notes payable, $500 of fees, and $14,929 of derivative liability resulting in a gain on settlement of debt of $1,321. On January 2, 2020, the Company issued 2,316,826 common shares with a fair value of $81,090 for the conversion of $40,000 of note payable, $3,167 of accrued interest, and $49,831 of derivative liability resulting in a gain on settlement of debt of $11,908. On January 2, 2020, the Company issued 1,567,942 common shares with a fair value of $54,878 for the conversion of $25,000 of note payable, $1,708 of accrued interest, and $36,380 of derivative liability resulting in a gain on settlement of $8,210. On January 2, 2020, the Company issued 892,857 common shares with a fair value of $31,250 for the conversion of $15,000 of note payable and $19,062 of derivative liability resulting in a gain on settlement of $2,812. On January 3, 2020, the Company issued 1,553,815 common shares with a fair value of $49,722 for the conversion of $21,500 of note payable, $3,530 of accrued interest, $500 of fees, and $26,692 of derivative liability resulting in a gain on settlement of $2,500. On January 3, 2020, the Company issued 2,000,000 common shares with a fair value of $64,000 for the conversion of $25,933 of note payable, $6,697 of accrued interest and $36,589 of derivative liability resulting in a gain on settlement of $5,219. On January 3, 2020, the Company issued 892,857 common shares with a fair value of $28,572 for the conversion of $15,000 of note payable and $16,833 of derivative liability resulting in a gain on settlement of $3,261. On January 6, 2020, the Company issued 860,000 common shares with a fair value of $25,800 for the conversion of $11,311 of note payable, $750 fees and $15,573 of derivative liability resulting in a gain on settlement of $1,834. On January 6, 2020, the Company issued 1,264,782 common shares with a fair value of $37,944 for the conversion of $20,000 of note payable, $94 of accrued interest, $500 of fees and $19,661 of derivative liability resulting in a gain on settlement of $2,311. On January 6, 2020, the Company issued 1,071,429 common shares with a fair value of $32,143 for the conversion of $18,000 of note payable and $17,815 of derivative liability resulting in a gain on settlement of $3,672. On January 7, 2020, the Company issued 802,381 common shares with a fair value of $24,874 for the conversion of $10,000 of note payable, $3,622 of accrued interest and $14,098 of derivative liability resulting in a gain on settlement of $2,846. On January 7, 2020, the Company issued 1,569,981 common shares with a fair value of $48,669 for the conversion of $25,000 of note payable, $1,743 of accrued interest and $27,445 of derivative liability resulting in a gain on settlement of $5,519. On January 10, 2020, the Company issued 1,395,332 common shares for a fair value of $35,581 for the conversion of $20,000 of note payable, $1,014 of accrued interest and $21,671 of derivative liability resulting in a gain on settlement of $7,104. On January 13, 2020, the Company issued 1,938,768 common shares for a fair value $52,347 for the conversion of $30,000 of note payable, $2,142 of accrued interest and $26,911 of derivative liability resulting in a gain on settlement of $6,706. On January 14, 2020, the Company issued 1,340,000 common shares for a fair value of $45,560 for the conversion of $17,306 of note payable, $750 of fees and $31,041 of derivative liability resulting in a gain on settlement of $3,537. On January 14, 2020, the Company issued 916,963 common shares for a fair value of $31,177 for the conversion of $14,000 of note payable, $600 of accrued interest, $500 of fees and $19,647 of derivative liability resulting in a gain on settlement of $3,570. On January 14, 2020, the Company issued 5,021,366 common shares for a fair value of $170,726 for the conversion of $79,067 of note payable, $572 accrued interest and $114,349 of derivative liability resulting in a gain on settlement of $23,262. On January 15, 2020, the Company issued 1,500,000 common shares for a fair value of $100,470 for the conversion of $19,462 of note payable, $750 of fees and $100,470 of derivative liability resulting in a gain on settlement of 21,212. On January 15, 2020, the Company issued 4,649,492 common shares for a fair value of $311,422 for the conversion of $75,000 of note payable, $5,938 of accrued interest and $247,423 derivative liability resulting in a gain on settlement of $16,939. On January 15, 2020, the Company issued 2,805,479 common shares for a fair value of $187,911 for the conversion of $40,000 of note payable, $2,082 of accrued interest and $154,571 of derivative liability resulting in a gain on settlement of $8,742. On January 15, 2020, the Company issued 3,232,955 common shares for a fair value of $216,543 for the conversion of $50,000 of note payable, $3,597 of accrued interest and $168,041 of derivative liability resulting in a gain on settlement of $5,095. On January 16, 2020, the Company issued 3,233,793 common shares for a fair value of $181,093 for the conversion of $50,000, accrued interest of $3,611 and derivative liability of $132,763 resulting in a gain on settlement of $5,281. On January 17, 2020, the Company issued 5,263,014 common shares for a fair value of $302,623 for the conversion of $75,000 of note payable, $3,945 of accrued interest and $242,111 of derivative liability resulting in a gain on settlement of $18,433. On January 22, 2020, the Company issued 2,591,056 common shares for a fair value of $82,914 for the conversion of $40,000 of note payable, $2,956 accrued interest and $53,413 of derivative liability resulting in a gain on settlement of $13,455. On January 23, 2020, the Company issued 1,757,077 common shares for a fair value of $70,248 for the conversion of $25,000 of note payable, $1,295 accrued interest and $52,557 of derivative liability resulting in a gain of settlement of $8,604. On January 23, 2020, the Company issued 3,761,200 common shares with a fair value of $150,448 for consulting services. On January 23, 2020, the Company issued 3,475,000 common shares with a fair value of $139,000 for consulting services including 1,000,000 common shares with a fair value of $40,000 to a director of the Company. On January 27, 2020, the Company issued 4,679,001 common shares with a fair value of $170,784 for the conversion of $75,000 of note payable, $6,793 of accrued interest and $150,648 of derivative liability resulting in a gain on settlement of $61,657. On January 27, 2020, the Company issued 2,594,407 common shares with a fair value of $94,695 for the conversion of $40,000 of note payable, $3,011 of accrued liability and $59,353 of derivative liability resulting in a gain on settlement of $7,669. On January 30, 2020, the Company issued 2,596,417 common shares with a fair value of $84,383 for the conversion of $40,000, $2,683 of accrued interest and $50,666 of derivative liability resulting in a gain on settlement of 8,966. On February 4, 2020, the Company issued 6,467,394 common shares with a fair value of $239,293 for the conversion of $98,000 of note payable, $5,907 of accrued interest, $105 of fees and $166,151 of derivative liability resulting in a gain on settlement of $30,870. On February 5, 2020, the Company issued 2,503,957 common shares with a fair value of $113,930 for the conversion of $40,000 of note payable, $3,589 of accrued interest and $72,495 of derivative liability resulting in a gain on settlement of $2,154. On February 5, 2020, the Company issued 670,000 common shares with a fair value of $30,485 for the conversion of $8,278 of note payable, $750 of fees and $22,106 of derivative liability resulting in a gain on settlement of $649. On February 6, 2020, the Company issued 5,026,425 common shares with a fair value of $201,057 for the conversion of $78,630 of note payable, $4,375 of accrued interest and $134,206 of derivative liability resulting in a gain on settlement of $16,154. On February 10, 2020, the Company issued 9,723,549 common shares with a fair value of $495,901 for the conversion of $150,000 of note payable, $11,096 of accrued interest, $105 of fees and $366,278 of derivative liability resulting in a gain on settlement of $31,578. On February 10, 2020, the Company issued 1,118,568 common shares with a fair value of $57,047 for the conversion of $20,000 of note payable and $37,087 of derivative liability resulting in a gain on settlement of $40. On February 10, 2020, the Company issued 7,834,840 common shares with a fair value of $399,577 for the conversion of $125,000 of note payable, $14,524 of accrued interest and $269,904 of derivative liability resulting in a gain on settlement of $9,851. On February 11, 2020, the Company issued 2,051,298 common shares with a fair value of $137,355 for the conversion of $18,641 of note payable, $4,564 of accrued interest, $1,500 of fees and $108,919 of derivative liability resulting in a gain on settlement of $3,731. On February 12, 2020, the Company issued 1,388,889 common shares with a fair value of $83,333 for the conversion of $25,000 of note payable and $65,150 of derivative liability resulting in a gain on settlement of $6,817. On February 14, 2020, the Company issued 2,688,172 common shares with a fair value of $161,290 for the conversion of $50,000 of note payable, $3,550 of accrued interest and $127,306 of derivative liability resulting in a gain on settlement of $19,566. On February 19, 2020, the Company issued 9,301,308 common shares with a fair value of $836,188 for the conversion of $175,000 of note payable, $14,529 of accrued interest, $105 of fees and $238,239 of derivative liability resulting in a loss on settlement on $408,315. On February 19, 2020, the Company issued 3,643,827 common shares with a fair value of $327,580 for the conversion of $60,000 of note payable, $5,472 of accrued interest and $327,580 of derivative liability resulting in a gain on settlement of $65,472. On February 24, 2020, the Company issued 10,000,000 common shares with a fair value of $400,000 for consulting services including 6,000,000 common shares with a fair value of $240,000 to three directors of the Company. On February 24, 2020, the Company issued 9,206,396 common shares with a fair value of $535,996 for the conversion of $175,000 of note payable, $12,705 of accrued interest, $105 of fees and $398,306 of derivative liability resulting in a gain on settlement of $50,120. On February 27, 2020, the Company issued 1,313,822 common shares for the exercise of cashless warrants. On March 1, 2020, the Company issued 2,104,577 common shares with a fair value of $99,967 for the conversion of $35,200 of note payable, $2,147 of accrued interest, $500 fees and $68,868 of derivative liability resulting in a gain on settlement of 6,748. On March 2, 2020, the Company issued 2,049,666 common shares with a fair value of $97,359 for the conversion of $35,200 of note payable, $2,159 of accrued interest, $500 of fees and $69,374 of derivative liability resulting in a gain on settlement of $9,874. On March 4, 2020, the Company issued 7,910,062 common shares with a fair value of $514,154 for the conversion of $150,000 of note payable, $11,635 of accrued interest, $105 of fees and $390,342 of derivative liability resulting in a gain on settlement of $37,928. On March 24, 2020, the Company issued 5,082,065 common shares with a fair value of $193,118 for the conversion of $90,000 of note payable. $6,657 of accrued interest, $105 of fees and $127,986 of derivative liability resulting in a gain on settlement of $31,630. During the period ended March 31, 2020, the Company received share subscriptions of $1,125,000 for the future issuance of private placement units at $0.04 per unit, where each unit is comprised of one common share of the Company and 0.8 share purchase warrant where each whole share purchase warrant can be exercised into one common share of the Company at $0.15 per share until October 31, 2024. As at the date of the filing, the private placement units have not been issued. |
8. Share Purchase Warrants
8. Share Purchase Warrants | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
8. Share Purchase Warrants | 8. Share Purchase Warrants Number of warrants Weighted average exercise price $ Balance, September 30, 2019 8,925,334 0.10 Granted 2,722,224 0.17 Exercised (4,310,807) 0.07 Balance, March 31, 2020 7,336,751 0.14 Additional information regarding share purchase warrants as of March 31, 2020, is as follows: Outstanding and exercisable Range of Exercise Prices $ Number of Warrants Remaining Contractual Life (years) 0.001 19,512 0.01 0.01 603,015 0.28 0.10 3,250,000 1.4 0.15 1,500,000 0.7 0.17 500,000 0.3 0.18 722,224 0.3 0.20 500,000 0.3 0.50 242,000 0.05 7,336,751 3.34 |
9. Subsequent Events
9. Subsequent Events | 6 Months Ended |
Mar. 31, 2020 | |
Notes | |
9. Subsequent Events | 9. Subsequent Events (a) (b) The Company has evaluated events occurring from March 31, 2020 through the date the financial statements were issued and determined that there are no additional events requiring disclosure |
1. Organization and Nature of_2
1. Organization and Nature of Operations: Going Concern (Policies) | 6 Months Ended |
Mar. 31, 2020 | |
Policies | |
Going Concern | Going Concern The recent outbreak of the novel coronavirus COVID-19, which was declared a pandemic by the World Health Organization on March 11, 2020, has led to adverse impacts on the U.S. and global economies, disruptions of financial markets, and created uncertainty regarding potential impacts to the CompanyÂ’s supply chain and operations. The COVID-19 pandemic has impacted and could further impact the CompanyÂ’s operations and the operations of the CompanyÂ’s suppliers and vendors as a result of quarantines, facility closures, and travel and logistics restrictions. The extent to which the COVID-19 pandemic impacts the CompanyÂ’s business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to the duration, spread, severity, and impact of the COVID-19 pandemic, the effects of the COVID-19 pandemic on the CompanyÂ’s suppliers and vendors and the remedial actions and stimulus measures adopted by local and federal governments, and to what extent normal economic and operating conditions can resume. The management team is closely following the progression of COVID-19 and its potential impact on the Company. Even after the COVID-19 pandemic has subsided, the Company may experience adverse impacts to its business as a result of any economic recession or depression that has occurred or may occur in the future. Therefore, the Company cannot reasonably estimate the impact at this time our business, liquidity, capital resources and financial results. These unaudited consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As at March 31, 2020, the Company has not earned revenue, has a working capital deficit of $4,767,984, and an accumulated deficit of $60,351,589. The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to identify future investment opportunities and obtain the necessary debt or equity financing, and generating profitable operations from the CompanyÂ’s future operations. If the Company is able to obtain financing, there is no certainty that terms will be favorable to the Company. These factors raise substantial doubt regarding the CompanyÂ’s ability to continue as a going concern. These unaudited consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. |
2. Summary of Significant Acc_2
2. Summary of Significant Accounting Policies: Basis of Presentation (Policies) | 6 Months Ended |
Mar. 31, 2020 | |
Policies | |
Basis of Presentation | (a) The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is September 30. |
2. Summary of Significant Acc_3
2. Summary of Significant Accounting Policies: Principles of Consolidation (Policies) | 6 Months Ended |
Mar. 31, 2020 | |
Policies | |
Principles of Consolidation | (b) These condensed consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Oroplata Exploraciones E Ingenieria SRL, Lithortech Resources Inc., and ABMC AG, LLC. All inter-company accounts and transactions have been eliminated on consolidation. |
6. Derivative Liabilities_ Sche
6. Derivative Liabilities: Schedule of inputs and assumptions used to value the derivative liabilities (Tables) | 6 Months Ended |
Mar. 31, 2020 | |
Tables/Schedules | |
Schedule of inputs and assumptions used to value the derivative liabilities | March 31, 2020 September 30, 2019 Expected volatility 70-319% 75-151% Risk free rate 1.41% 1.75% Expected life (in years) 0.2-1.0 0.2-1.0 |
6. Derivative Liabilities_ Sc_2
6. Derivative Liabilities: Schedule of activity of the derivative liabilities (Tables) | 6 Months Ended |
Mar. 31, 2020 | |
Tables/Schedules | |
Schedule of activity of the derivative liabilities | $ Balance, September 30, 2019 3,437,200 Derivative additions associated with convertible notes 2,029,525 Adjustment for conversion/repayment (5,313,818) Mark to market adjustment at March 31, 2020 3,623,387 Balance, March 31, 2020 3,776,294 |
8. Share Purchase Warrants_ Sch
8. Share Purchase Warrants: Schedule of Additional information regarding share purchase warrants (Tables) | 6 Months Ended |
Mar. 31, 2020 | |
Tables/Schedules | |
Schedule of Additional information regarding share purchase warrants | Outstanding and exercisable Range of Exercise Prices $ Number of Warrants Remaining Contractual Life (years) 0.001 19,512 0.01 0.01 603,015 0.28 0.10 3,250,000 1.4 0.15 1,500,000 0.7 0.17 500,000 0.3 0.18 722,224 0.3 0.20 500,000 0.3 0.50 242,000 0.05 7,336,751 3.34 |
1. Organization and Nature of_3
1. Organization and Nature of Operations: Going Concern (Details) - USD ($) | Mar. 31, 2020 | Sep. 30, 2019 |
Details | ||
Working capital deficit | $ 4,767,984 | |
Accumulated deficit | $ (60,351,589) | $ (49,890,538) |
3. Convertible Notes Payable (D
3. Convertible Notes Payable (Details) | 6 Months Ended |
Mar. 31, 2020USD ($) | |
Convertible Note 1 | |
Debt Instrument, Issuance Date | Apr. 8, 2019 |
Debt Instrument, Face Amount | $ 38,500 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 2 | |
Debt Instrument, Issuance Date | Apr. 8, 2019 |
Debt Instrument, Face Amount | $ 38,500 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 3 | |
Debt Instrument, Issuance Date | May 1, 2019 |
Debt Instrument, Face Amount | $ 325,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 4 | |
Debt Instrument, Issuance Date | May 1, 2019 |
Debt Instrument, Face Amount | $ 325,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 5 | |
Debt Instrument, Issuance Date | May 29, 2019 |
Debt Instrument, Face Amount | $ 325,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 6 | |
Debt Instrument, Issuance Date | Jun. 3, 2019 |
Debt Instrument, Face Amount | $ 55,000 |
Debt Instrument, Interest Rate, Stated Percentage | 22.00% |
Convertible Note 7 | |
Debt Instrument, Issuance Date | Jun. 11, 2019 |
Debt Instrument, Face Amount | $ 105,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 8 | |
Debt Instrument, Issuance Date | Jun. 12, 2019 |
Debt Instrument, Face Amount | $ 55,000 |
Debt Instrument, Interest Rate, Stated Percentage | 22.00% |
Convertible Note 9 | |
Debt Instrument, Issuance Date | Jun. 12, 2019 |
Debt Instrument, Face Amount | $ 55,000 |
Debt Instrument, Interest Rate, Stated Percentage | 22.00% |
Convertible Note 10 | |
Debt Instrument, Issuance Date | Jun. 13, 2019 |
Debt Instrument, Face Amount | $ 75,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 11 | |
Debt Instrument, Issuance Date | Jun. 21, 2019 |
Debt Instrument, Face Amount | $ 270,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 12 | |
Debt Instrument, Issuance Date | Jun. 27, 2019 |
Debt Instrument, Face Amount | $ 98,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 13 | |
Debt Instrument, Issuance Date | Jun. 27, 2019 |
Debt Instrument, Face Amount | $ 58,000 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 14 | |
Debt Instrument, Issuance Date | Jul. 9, 2019 |
Debt Instrument, Face Amount | $ 160,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 15 | |
Debt Instrument, Issuance Date | Jul. 11, 2019 |
Debt Instrument, Face Amount | $ 50,000 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 16 | |
Debt Instrument, Issuance Date | Jul. 29, 2019 |
Debt Instrument, Face Amount | $ 53,000 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 17 | |
Debt Instrument, Issuance Date | Aug. 1, 2019 |
Debt Instrument, Face Amount | $ 175,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 18 | |
Debt Instrument, Issuance Date | Aug. 8, 2019 |
Debt Instrument, Face Amount | $ 105,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 19 | |
Debt Instrument, Issuance Date | Aug. 12, 2019 |
Debt Instrument, Face Amount | $ 105,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 20 | |
Debt Instrument, Issuance Date | Aug. 28, 2019 |
Debt Instrument, Face Amount | $ 35,200 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 21 | |
Debt Instrument, Issuance Date | Aug. 28, 2019 |
Debt Instrument, Face Amount | $ 35,200 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 22 | |
Debt Instrument, Issuance Date | Aug. 28, 2019 |
Debt Instrument, Face Amount | $ 110,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 23 | |
Debt Instrument, Issuance Date | Sep. 13, 2019 |
Debt Instrument, Face Amount | $ 175,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 24 | |
Debt Instrument, Issuance Date | Sep. 17, 2019 |
Debt Instrument, Face Amount | $ 150,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 25 | |
Debt Instrument, Issuance Date | Sep. 24, 2019 |
Debt Instrument, Face Amount | $ 55,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 26 | |
Debt Instrument, Issuance Date | Sep. 24, 2019 |
Debt Instrument, Face Amount | $ 48,000 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 27 | |
Debt Instrument, Issuance Date | Oct. 15, 2019 |
Debt Instrument, Face Amount | $ 52,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 28 | |
Debt Instrument, Issuance Date | Oct. 15, 2019 |
Debt Instrument, Face Amount | $ 29,150 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 29 | |
Debt Instrument, Issuance Date | Oct. 15, 2019 |
Debt Instrument, Face Amount | $ 29,150 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 30 | |
Debt Instrument, Issuance Date | Oct. 31, 2019 |
Debt Instrument, Face Amount | $ 43,000 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 31 | |
Debt Instrument, Issuance Date | Nov. 1, 2019 |
Debt Instrument, Face Amount | $ 20,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 32 | |
Debt Instrument, Issuance Date | Nov. 4, 2019 |
Debt Instrument, Face Amount | $ 113,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 33 | |
Debt Instrument, Issuance Date | Nov. 4, 2019 |
Debt Instrument, Face Amount | $ 46,200 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 34 | |
Debt Instrument, Issuance Date | Dec. 9, 2019 |
Debt Instrument, Face Amount | $ 47,300 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 35 | |
Debt Instrument, Issuance Date | Dec. 23, 2019 |
Debt Instrument, Face Amount | $ 43,000 |
Debt Instrument, Interest Rate, Stated Percentage | 12.00% |
Convertible Note 36 | |
Debt Instrument, Issuance Date | Jan. 31, 2020 |
Debt Instrument, Face Amount | $ 147,250 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 37 | |
Debt Instrument, Issuance Date | Jan. 31, 2020 |
Debt Instrument, Face Amount | $ 147,250 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 38 | |
Debt Instrument, Issuance Date | Feb. 7, 2020 |
Debt Instrument, Face Amount | $ 177,200 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 39 | |
Debt Instrument, Issuance Date | Feb. 14, 2020 |
Debt Instrument, Face Amount | $ 83,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 40 | |
Debt Instrument, Issuance Date | Feb. 14, 2020 |
Debt Instrument, Face Amount | $ 75,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 41 | |
Debt Instrument, Issuance Date | Feb. 18, 2020 |
Debt Instrument, Face Amount | $ 110,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 42 | |
Debt Instrument, Issuance Date | Feb. 18, 2020 |
Debt Instrument, Face Amount | $ 110,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 43 | |
Debt Instrument, Issuance Date | Feb. 19, 2020 |
Debt Instrument, Face Amount | $ 220,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
Convertible Note 44 | |
Debt Instrument, Issuance Date | Mar. 17, 2020 |
Debt Instrument, Face Amount | $ 520,000 |
Debt Instrument, Interest Rate, Stated Percentage | 10.00% |
4. Related Party Transactions (
4. Related Party Transactions (Details) - USD ($) | 6 Months Ended | |
Mar. 31, 2020 | Sep. 30, 2019 | |
Due to related parties | $ 562,449 | $ 458,269 |
Transaction 1 | ||
Due to related parties | $ 120,146 | 120,146 |
Related Party Transaction, Description of Transaction | advances to the Company to fund day-to-day operations | |
Transaction 2 | ||
Due to related parties | $ 85,500 | 85,500 |
Related Party Transaction, Description of Transaction | advances to the Company to fund day-to-day operations and accrued management fees | |
Transaction 3 | ||
Due to related parties | $ 326,077 | 221,897 |
Related Party Transaction, Description of Transaction | accrued management fees | |
Transaction 4 | ||
Due to related parties | $ 30,726 | $ 30,726 |
Related Party Transaction, Description of Transaction | accrued management fees |
6. Derivative Liabilities (Deta
6. Derivative Liabilities (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | Mar. 31, 2020 | Mar. 31, 2019 | Sep. 30, 2019 | |
Details | |||||
Change in fair value of derivative liability | $ (3,558,652) | $ (235,853) | $ (3,623,387) | $ (944,008) | $ 944,008 |
Derivative Liability, Current | $ 3,776,294 | $ 3,776,294 | $ 3,437,200 |
6. Derivative Liabilities_ Sc_3
6. Derivative Liabilities: Schedule of inputs and assumptions used to value the derivative liabilities (Details) - Derivative liabilities | 6 Months Ended | 12 Months Ended |
Mar. 31, 2020 | Sep. 30, 2019 | |
Fair Value Assumptions, Expected Volatility Rate | 0.7500 | |
Fair Value Assumptions, Risk Free Interest Rate | 0.0141 | 0.0175 |
Expected life (in years) | 1 year | |
Minimum | ||
Fair Value Assumptions, Expected Volatility Rate | 0.7000 | |
Expected life (in years) | 2 months 12 days | |
Maximum | ||
Fair Value Assumptions, Expected Volatility Rate | 3.1900 | |
Expected life (in years) | 1 year |
6. Derivative Liabilities_ Sc_4
6. Derivative Liabilities: Schedule of activity of the derivative liabilities (Details) | 6 Months Ended |
Mar. 31, 2020USD ($) | |
Details | |
Derivative Liabilities, starting balance | $ 3,437,200 |
Derivative additions associated with convertible notes | 2,029,525 |
Adjustment for conversion | (5,313,818) |
Mark-to-market adjustments | 3,623,387 |
Derivative Liabilities, ending balance | $ 3,776,294 |
7. Common Stock (Details)
7. Common Stock (Details) - USD ($) | 6 Months Ended | |
Mar. 31, 2020 | Sep. 30, 2019 | |
Common Stock, Shares Authorized | 1,200,000,000 | 1,200,000,000 |
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock, Shares Authorized | 500,000 | 500,000 |
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Share subscription received | $ 1,125,000 | $ 0 |
Stock transaction 1 | ||
Sale of Stock, Transaction Date | Oct. 1, 2019 | |
Stock Issued During Period, Shares, New Issues | 300,000 | |
Stock transaction 2 | ||
Sale of Stock, Transaction Date | Oct. 3, 2019 | |
Stock Issued During Period, Shares, New Issues | 917,777 | |
Stock Issued | $ 49,560 | |
Stock transaction 3 | ||
Sale of Stock, Transaction Date | Oct. 8, 2019 | |
Stock Issued During Period, Shares, New Issues | 577,496 | |
Stock Issued | $ 31,185 | |
Stock transaction 4 | ||
Sale of Stock, Transaction Date | Oct. 10, 2019 | |
Stock Issued During Period, Shares, New Issues | 2,036,114 | |
Stock Issued | $ 97,733 | |
Stock transaction 5 | ||
Sale of Stock, Transaction Date | Oct. 15, 2019 | |
Stock Issued During Period, Shares, New Issues | 465,723 | |
Stock Issued | $ 29,341 | |
Stock transaction 6 | ||
Sale of Stock, Transaction Date | Oct. 17, 2019 | |
Stock Issued During Period, Shares, New Issues | 502,980 | |
Stock Issued | $ 25,149 | |
Stock transaction 7 | ||
Sale of Stock, Transaction Date | Oct. 18, 2019 | |
Stock Issued During Period, Shares, New Issues | 1,113,981 | |
Stock Issued | $ 54,028 | |
Stock transaction 8 | ||
Sale of Stock, Transaction Date | Oct. 21, 2019 | |
Stock Issued During Period, Shares, New Issues | 542,526 | |
Stock Issued | $ 29,242 | |
Stock transaction 9 | ||
Sale of Stock, Transaction Date | Oct. 25, 2019 | |
Stock Issued During Period, Shares, New Issues | 559,768 | |
Stock Issued | $ 27,429 | |
Stock transaction 10 | ||
Sale of Stock, Transaction Date | Oct. 25, 2019 | |
Stock Issued During Period, Shares, New Issues | 481,557 | |
Stock Issued | $ 23,596 | |
Stock Transaction 11 | ||
Sale of Stock, Transaction Date | Oct. 28, 2019 | |
Stock Issued During Period, Shares, New Issues | 2,996,985 | |
Stock transaction 12 | ||
Sale of Stock, Transaction Date | Oct. 30, 2019 | |
Stock Issued During Period, Shares, New Issues | 744,949 | |
Stock Issued | $ 36,503 | |
Stock transaction 13 | ||
Sale of Stock, Transaction Date | Oct. 31, 2019 | |
Stock Issued During Period, Shares, New Issues | 500,000 | |
Stock Issued | $ 24,500 | |
Stock transaction 14 | ||
Sale of Stock, Transaction Date | Nov. 4, 2019 | |
Stock Issued During Period, Shares, New Issues | 820,497 | |
Stock Issued | $ 33,640 | |
Stock transaction 15 | ||
Sale of Stock, Transaction Date | Nov. 8, 2019 | |
Stock Issued During Period, Shares, New Issues | 815,396 | |
Stock Issued | $ 35.877 | |
Stock transaction 16 | ||
Sale of Stock, Transaction Date | Nov. 8, 2019 | |
Stock Issued During Period, Shares, New Issues | 5,560,000 | |
Stock Issued | $ 233,520 | |
Stock transaction 17 | ||
Sale of Stock, Transaction Date | Nov. 12, 2019 | |
Stock Issued During Period, Shares, New Issues | 972,587 | |
Stock Issued | $ 39,876 | |
Stock transaction 18 | ||
Sale of Stock, Transaction Date | Nov. 20, 2019 | |
Stock Issued During Period, Shares, New Issues | 994,354 | |
Stock Issued | $ 35,797 | |
Stock transaction 19 | ||
Sale of Stock, Transaction Date | Nov. 20, 2019 | |
Stock Issued During Period, Shares, New Issues | 1,986,954 | |
Stock Issued | $ 71,531 | |
Stock transaction 20 | ||
Sale of Stock, Transaction Date | Nov. 21, 2019 | |
Stock Issued During Period, Shares, New Issues | 850,000 | |
Stock Issued | $ 34,000 | |
Stock transaction 21 | ||
Sale of Stock, Transaction Date | Nov. 29, 2019 | |
Stock Issued During Period, Shares, New Issues | 996,680 | |
Stock Issued | $ 37,874 | |
Stock transaction 22 | ||
Sale of Stock, Transaction Date | Dec. 6, 2019 | |
Stock Issued During Period, Shares, New Issues | 607,477 | |
Stock Issued | $ 20,958 | |
Stock transaction 23 | ||
Sale of Stock, Transaction Date | Dec. 9, 2019 | |
Stock Issued During Period, Shares, New Issues | 746,269 | |
Stock Issued | $ 25,224 | |
Stock transaction 24 | ||
Sale of Stock, Transaction Date | Dec. 10, 2019 | |
Stock Issued During Period, Shares, New Issues | 999,524 | |
Stock Issued | $ 32,984 | |
Stock transaction 25 | ||
Sale of Stock, Transaction Date | Dec. 11, 2019 | |
Stock Issued During Period, Shares, New Issues | 845,771 | |
Stock Issued | $ 25,458 | |
Stock transaction 26 | ||
Sale of Stock, Transaction Date | Dec. 12, 2019 | |
Stock Issued During Period, Shares, New Issues | 700,000 | |
Stock Issued | $ 22,820 | |
Stock transaction 27 | ||
Sale of Stock, Transaction Date | Dec. 13, 2019 | |
Stock Issued During Period, Shares, New Issues | 703,704 | |
Stock Issued | $ 22,167 | |
Stock transaction 28 | ||
Sale of Stock, Transaction Date | Dec. 13, 2019 | |
Stock Issued During Period, Shares, New Issues | 822,281 | |
Stock Issued | $ 25,902 | |
Stock transaction 29 | ||
Sale of Stock, Transaction Date | Dec. 16, 2019 | |
Stock Issued During Period, Shares, New Issues | 2,079,180 | |
Stock Issued | $ 62,375 | |
Stock transaction 30 | ||
Sale of Stock, Transaction Date | Dec. 16, 2019 | |
Stock Issued During Period, Shares, New Issues | 567,874 | |
Stock Issued | $ 17,036 | |
Stock transaction 31 | ||
Sale of Stock, Transaction Date | Dec. 17, 2019 | |
Stock Issued During Period, Shares, New Issues | 1,047,754 | |
Stock Issued | $ 35,624 | |
Stock transaction 32 | ||
Sale of Stock, Transaction Date | Dec. 24, 2019 | |
Stock Issued During Period, Shares, New Issues | 932,920 | |
Stock Issued | $ 38,670 | |
Stock transaction 33 | ||
Sale of Stock, Transaction Date | Dec. 24, 2019 | |
Stock Issued During Period, Shares, New Issues | 1,561,157 | |
Stock Issued | $ 64,710 | |
Stock transaction 34 | ||
Sale of Stock, Transaction Date | Dec. 27, 2019 | |
Stock Issued During Period, Shares, New Issues | 896,925 | |
Stock Issued | $ 30,047 | |
Stock transaction 35 | ||
Sale of Stock, Transaction Date | Dec. 30, 2019 | |
Stock Issued During Period, Shares, New Issues | 1,164,572 | |
Stock Issued | $ 32,608 | |
Stock Transaction 36 | ||
Sale of Stock, Transaction Date | Jan. 2, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,316,826 | |
Stock Issued | $ 81,090 | |
Stock Transaction 37 | ||
Sale of Stock, Transaction Date | Jan. 2, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,567,942 | |
Stock Issued | $ 54,878 | |
Stock Transaction 38 | ||
Sale of Stock, Transaction Date | Jan. 2, 2020 | |
Stock Issued During Period, Shares, New Issues | 892,857 | |
Stock Issued | $ 31,250 | |
Stock Transaction 39 | ||
Sale of Stock, Transaction Date | Jan. 3, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,553,815 | |
Stock Issued | $ 49,722 | |
Stock Transaction 40 | ||
Sale of Stock, Transaction Date | Jan. 3, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,000,000 | |
Stock Issued | $ 64,000 | |
Stock Transaction 41 | ||
Sale of Stock, Transaction Date | Jan. 3, 2020 | |
Stock Issued During Period, Shares, New Issues | 892,857 | |
Stock Issued | $ 28,572 | |
Stock Transaction 42 | ||
Sale of Stock, Transaction Date | Jan. 6, 2020 | |
Stock Issued During Period, Shares, New Issues | 860,000 | |
Stock Issued | $ 25,800 | |
Stock Transaction 43 | ||
Sale of Stock, Transaction Date | Jan. 6, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,264,782 | |
Stock Issued | $ 37,944 | |
Stock Transaction 44 | ||
Sale of Stock, Transaction Date | Jan. 6, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,071,429 | |
Stock Issued | $ 32,143 | |
Stock Transaction 45 | ||
Sale of Stock, Transaction Date | Jan. 7, 2020 | |
Stock Issued During Period, Shares, New Issues | 802,381 | |
Stock Issued | $ 24,874 | |
Stock Transaction 46 | ||
Sale of Stock, Transaction Date | Jan. 7, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,569,981 | |
Stock Issued | $ 48,669 | |
Stock Transaction 47 | ||
Sale of Stock, Transaction Date | Jan. 10, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,395,332 | |
Stock Issued | $ 35,581 | |
Stock Transaction 48 | ||
Sale of Stock, Transaction Date | Jan. 13, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,938,768 | |
Stock Issued | $ 52,347 | |
Stock Transaction 49 | ||
Sale of Stock, Transaction Date | Jan. 14, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,340,000 | |
Stock Issued | $ 45,560 | |
Stock Transaction 50 | ||
Sale of Stock, Transaction Date | Jan. 14, 2020 | |
Stock Issued During Period, Shares, New Issues | 916,963 | |
Stock Issued | $ 31,177 | |
Stock Transaction 51 | ||
Sale of Stock, Transaction Date | Jan. 14, 2020 | |
Stock Issued During Period, Shares, New Issues | 5,021,366 | |
Stock Issued | $ 170,726 | |
Stock Transaction 52 | ||
Sale of Stock, Transaction Date | Jan. 15, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,500,000 | |
Stock Issued | $ 100,470 | |
Stock Transaction 53 | ||
Sale of Stock, Transaction Date | Jan. 15, 2020 | |
Stock Issued During Period, Shares, New Issues | 4,649,492 | |
Stock Issued | $ 311,422 | |
Stock Transaction 54 | ||
Sale of Stock, Transaction Date | Jan. 15, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,805,479 | |
Stock Issued | $ 187,911 | |
Stock Transaction 55 | ||
Sale of Stock, Transaction Date | Jan. 15, 2020 | |
Stock Issued During Period, Shares, New Issues | 3,232,955 | |
Stock Issued | $ 216,543 | |
Stock Transaction 56 | ||
Sale of Stock, Transaction Date | Jan. 16, 2020 | |
Stock Issued During Period, Shares, New Issues | 3,233,793 | |
Stock Issued | $ 181,093 | |
Stock Transaction 57 | ||
Sale of Stock, Transaction Date | Jan. 17, 2020 | |
Stock Issued During Period, Shares, New Issues | 5,263,014 | |
Stock Issued | $ 302,623 | |
Stock Transaction 58 | ||
Sale of Stock, Transaction Date | Jan. 22, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,591,056 | |
Stock Issued | $ 82,914 | |
Stock Transaction 59 | ||
Sale of Stock, Transaction Date | Jan. 23, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,757,077 | |
Stock Issued | $ 70,248 | |
Stock Transaction 60 | ||
Sale of Stock, Transaction Date | Jan. 23, 2020 | |
Stock Issued During Period, Shares, New Issues | 3,761,200 | |
Stock Issued | $ 150,448 | |
Stock Transaction 61 | ||
Sale of Stock, Transaction Date | Jan. 23, 2020 | |
Stock Issued During Period, Shares, New Issues | 3,475,000 | |
Stock Issued | $ 139,000 | |
Stock Transaction 62 | ||
Sale of Stock, Transaction Date | Jan. 27, 2020 | |
Stock Issued During Period, Shares, New Issues | 4,679,001 | |
Stock Issued | $ 170,784 | |
Stock Transaction 63 | ||
Sale of Stock, Transaction Date | Jan. 27, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,594,407 | |
Stock Issued | $ 94,695 | |
Stock Transaction 64 | ||
Sale of Stock, Transaction Date | Jan. 30, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,596,417 | |
Stock Issued | $ 84,383 | |
Stock Transaction 65 | ||
Sale of Stock, Transaction Date | Feb. 4, 2020 | |
Stock Issued During Period, Shares, New Issues | 6,467,394 | |
Stock Issued | $ 239,293 | |
Stock Transaction 66 | ||
Sale of Stock, Transaction Date | Feb. 5, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,503,957 | |
Stock Issued | $ 113,930 | |
Stock Transaction 67 | ||
Sale of Stock, Transaction Date | Feb. 5, 2020 | |
Stock Issued During Period, Shares, New Issues | 670,000 | |
Stock Issued | $ 30,485 | |
Stock Transaction 68 | ||
Sale of Stock, Transaction Date | Feb. 6, 2020 | |
Stock Issued During Period, Shares, New Issues | 5,026,425 | |
Stock Issued | $ 201,057 | |
Stock Transaction 69 | ||
Sale of Stock, Transaction Date | Feb. 10, 2020 | |
Stock Issued During Period, Shares, New Issues | 9,723,549 | |
Stock Issued | $ 495,901 | |
Stock Transaction 70 | ||
Sale of Stock, Transaction Date | Feb. 10, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,118,568 | |
Stock Issued | $ 57,047 | |
Stock Transaction 71 | ||
Sale of Stock, Transaction Date | Feb. 10, 2020 | |
Stock Issued During Period, Shares, New Issues | 7,834,840 | |
Stock Issued | $ 399,577 | |
Stock Transaction 72 | ||
Sale of Stock, Transaction Date | Feb. 11, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,051,298 | |
Stock Issued | $ 137,355 | |
Stock Transaction 73 | ||
Sale of Stock, Transaction Date | Feb. 12, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,388,889 | |
Stock Issued | $ 83,333 | |
Stock Transaction 74 | ||
Sale of Stock, Transaction Date | Feb. 14, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,688,172 | |
Stock Issued | $ 161,290 | |
Stock Transaction 75 | ||
Sale of Stock, Transaction Date | Feb. 19, 2020 | |
Stock Issued During Period, Shares, New Issues | 9,301,308 | |
Stock Issued | $ 836,188 | |
Stock Transaction 76 | ||
Sale of Stock, Transaction Date | Feb. 19, 2020 | |
Stock Issued During Period, Shares, New Issues | 3,643,827 | |
Stock Issued | $ 327,580 | |
Stock Transaction 77 | ||
Sale of Stock, Transaction Date | Feb. 24, 2020 | |
Stock Issued During Period, Shares, New Issues | 10,000,000 | |
Stock Issued | $ 400,000 | |
Stock Transaction 78 | ||
Sale of Stock, Transaction Date | Feb. 24, 2020 | |
Stock Issued During Period, Shares, New Issues | 9,206,396 | |
Stock Issued | $ 535,996 | |
Stock Transaction 79 | ||
Sale of Stock, Transaction Date | Feb. 27, 2020 | |
Stock Issued During Period, Shares, New Issues | 1,313,822 | |
Stock Transaction 80 | ||
Sale of Stock, Transaction Date | Mar. 1, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,104,577 | |
Stock Issued | $ 99,967 | |
Stock Transaction 81 | ||
Sale of Stock, Transaction Date | Mar. 2, 2020 | |
Stock Issued During Period, Shares, New Issues | 2,049,666 | |
Stock Issued | $ 97,359 | |
Stock Transaction 82 | ||
Sale of Stock, Transaction Date | Mar. 4, 2020 | |
Stock Issued During Period, Shares, New Issues | 7,910,062 | |
Stock Issued | $ 514,154 | |
Stock Transaction 83 | ||
Sale of Stock, Transaction Date | Mar. 24, 2020 | |
Stock Issued During Period, Shares, New Issues | 5,082,065 | |
Stock Issued | $ 193,118 | |
Stock Transaction 84 | ||
Sale of Stock, Description of Transaction | Company received share subscriptions of $1,125,000 for the future issuance of private placement units | |
Share subscription received | $ 1,125,000 | |
Stock Transaction 84 | Minimum | ||
Sale of Stock, Transaction Date | Oct. 1, 2019 | |
Stock Transaction 84 | Maximum | ||
Sale of Stock, Transaction Date | Mar. 31, 2010 |
8. Share Purchase Warrants (Det
8. Share Purchase Warrants (Details) | 6 Months Ended |
Mar. 31, 2020$ / sharesshares | |
Details | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance | shares | 8,925,334 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance | $ / shares | $ 0.10 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 2,722,224 |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares | $ 0.17 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | (4,310,807) |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares | $ 0.07 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | shares | 7,336,751 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance | $ / shares | $ 0.14 |
8. Share Purchase Warrants_ S_2
8. Share Purchase Warrants: Schedule of Additional information regarding share purchase warrants (Details) | 6 Months Ended |
Mar. 31, 2020shares | |
Number of Warrants Outstanding and Exercisable | 7,336,751 |
Remaining Contractual Life (years) | 3 years 4 months 2 days |
0.001 | |
Number of Warrants Outstanding and Exercisable | 19,512 |
Remaining Contractual Life (years) | 4 days |
0.01 | |
Number of Warrants Outstanding and Exercisable | 603,015 |
Remaining Contractual Life (years) | 3 months 11 days |
0.10 | |
Number of Warrants Outstanding and Exercisable | 3,250,000 |
Remaining Contractual Life (years) | 1 year 4 months 24 days |
0.15 | |
Number of Warrants Outstanding and Exercisable | 1,500,000 |
Remaining Contractual Life (years) | 8 months 12 days |
0.17 | |
Number of Warrants Outstanding and Exercisable | 500,000 |
Remaining Contractual Life (years) | 3 months 18 days |
0.18 | |
Number of Warrants Outstanding and Exercisable | 722,224 |
Remaining Contractual Life (years) | 3 months 18 days |
0.20 | |
Number of Warrants Outstanding and Exercisable | 500,000 |
Remaining Contractual Life (years) | 3 months 18 days |
0.50 | |
Number of Warrants Outstanding and Exercisable | 242,000 |
Remaining Contractual Life (years) | 18 days |
9. Subsequent Events (Details)
9. Subsequent Events (Details) | 6 Months Ended |
Mar. 31, 2020shares | |
Event 1 | |
Subsequent Event, Description | Company received $400,000 of share subscriptions for the future issuance of private placement units at $0.04 per unit |
Event 1 | Minimum | |
Subsequent Event, Date | Apr. 1, 2020 |
Event 1 | Maximum | |
Subsequent Event, Date | Apr. 30, 2020 |
Event 2 | |
Subsequent Event, Description | Company issued 17,918,056 common shares |
Stock Issued During Period, Shares, New Issues | 17,918,056 |
Event 2 | Minimum | |
Subsequent Event, Date | Apr. 1, 2020 |
Event 2 | Maximum | |
Subsequent Event, Date | May 11, 2020 |